Skip to main content
logo
Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.040
-0.050 (-4.59%)
At close: Nov 6, 2026, 4:00 PM EST
1.060
+0.020 (1.92%)
After-hours: Nov 6, 2026, 7:57 PM EST

Allogene Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-190.89-257.59-327.27-340.41-182.05
Depreciation & Amortization
12.3613.6414.214.310.45
Asset Writedown & Restructuring Costs
2.3815.7213.25--
Loss (Gain) From Sale of Investments
-4.22-6.390.192.896.96
Loss (Gain) on Equity Investments
-1.6910.6712.884.09
Stock-Based Compensation
37.6451.7465.9583.680.82
Other Operating Activities
4.365.696.582.33-73.13
Change in Accounts Payable
-1.23-0.5-7.54.87-0.77
Change in Unearned Revenue
----0.02-38.3
Change in Other Net Operating Assets
-9.65-24.3-13.81-0.957.12
Operating Cash Flow
-149.25-200.3-237.73-220.52-184.81
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.39-0.69-1.52-5.19-21.45
Investment in Securities
95.9576.38164.81111.35185.1
Investing Cash Flow
95.5675.69163.29106.16163.66

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
23.25114.495.72.9511.96
Other Financing Activities
6.912.28---
Financing Cash Flow
30.16116.6895.72.9511.96

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-23.53-7.9421.25-111.41-9.19

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-149.63-200.99-239.25-225.71-206.26
Free Cash Flow Growth
-----
Free Cash Flow Margin
--913609.09%-251841.05%-144685.90%-180.79%
Free Cash Flow Per Share
-0.68-1.03-1.52-1.58-1.52
Levered Free Cash Flow
-80.73-99.13-134.26-111.74-85.97
Unlevered Free Cash Flow
-80.06-99.02-134.26-111.74-85.97

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-10.88-24.8-21.313.9-31.95
SEC Filings: 10-K · 10-Q